(IN BRIEF) SCHOTT Pharma delivered a resilient performance during the first half of fiscal year 2026, reporting revenue growth despite ongoing market challenges and maintaining strong profitability. The company benefited from continued demand for high-value pharmaceutical containment products, especially sterile … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, Pharma & Biotech, Science, Technology
Tagged biologics, cartriQ BioPure, Christian Mias, drug containment solutions, drug delivery systems, EBITDA, Frankfurt Stock Exchange, Free cash flow, Germany, GLP-1 therapies, Healthcare Innovation, high-value solutions, Hungary, HVS, injectable drugs, Mainz, mRNA Vaccines, pharmaceutical manufacturing, pharmaceutical packaging, polymer syringes, prefillable glass syringes, Reinhard Mayer, SCHOTT Pharma, SCHOTT Pharma Confirms 2026 Outlook Following Resilient First-Half Results and Expansion Investments, SCHOTT Pharma Maintains Stable Growth and Doubles Free Cash Flow in First Half of Fiscal 2026, SCHOTT Pharma Strengthens Financial Position as Demand for High-Value Drug Solutions Continues to Rise, SDAX, specialty vials, sterile cartridges, Switzerland
(IN BRIEF) SCHOTT Pharma has begun construction on a new production facility for ready-to-use (RTU) cartridges at its Lukácsháza site in Hungary. The investment of over 100 million euros will expand the company’s manufacturing capacity to meet increasing demand for … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Hungary, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged Andreas Reisse, biologics, Diabetes, Eva Szabó, expansion, GLP-1 drugs, high-value solutions, hormone therapies, Hungary, insulin, investment, Lukácsháza, manufacturing capacity, Ministry of Foreign Affairs and Trade, Obesity, partnership, pharmaceutical industry, pharmaceutical packaging, ready-to-use cartridges, SCHOTT Pharma, sterile cartridges, sustainability, sustainable development
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?